Skip to main content

Table 1 Baseline demographic, clinical, electrocardiographic, and echocardiographic characteristics

From: Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry

Characteristics(N = 419)
Demographic data
 Age (years), mean ± SD65.08 ± 11.30
 Male, n (%)306 (73.0%)
Diabetes, n (%)181 (43.2%)
Hypertension, n (%)315 (75.2%)
Chronic kidney disease, n (%)123 (29.4%)
Dyslipidemia, n (%)363 (86.6%)
Chronic stable angina, n (%)34 (8.1%)
History of myocardial infarction, n (%)259 (61.8%)
Stroke (ischemic), n (%)38 (9.1%)
Peripheral vascular disease, n (%)18 (4.3%)
NYHA FC, n (%)
 182 (20.6%)
 2238 (59.8%)
 368 (17.1%)
 410 (2.5%)
Electrocardiographic data
Rhythm, n (%)342 (87.7%)
 Sinus Rhythm, n (%)33 (8.5%)
 Atrial fibrillation n (%) 
Rate (bpm), mean ± SD76.4 ± 18.5
Systolic Blood pressure mmHg123.5 ± 20.4
Diastolic Blood pressure mmHg70.6 ± 12.7
Echocardiographic data
 LVEF (%) by Simpson’s method, mean ± SD29.99 ± 7.68
 LVEF (%) by Teicholz’s method, mean ± SD31.59 ± 9.42
 LVESD (mm) by M-mode, mean ± SD52.90 ± 17.04
 LVEDD (mm) by M-mode, median (min, max)62.00 (0.58, 560.00)
 Mitral E wave velocity, mean ± SD m/s70.68 ± 34.28
 Mitral A wave velocity, mean ± SD m/s65.11 ± 32.11
 LV thrombus, n (%)20 (5.2%)
  1. Abbreviations: SD standard deviation; NYHA FC New York Heart Association Functional Classification; bpm beats per minute; LVEF left ventricular ejection fraction; LVESD left ventricular end-systolic diameter; LVEDD left ventricular end-diastolic diameter